Corvus Pharmaceuticals
CRVS
CRVS
38 hedge funds and large institutions have $58.1M invested in Corvus Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
14% less capital invested
Capital invested by funds: $67.5M → $58.1M (-$9.44M)
46% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 13
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
38
Holding in Top 10
1
Calls
$361K
Puts
$144K
Top Buyers
| 1 | +$712K | |
| 2 | +$673K | |
| 3 | +$133K | |
| 4 |
Truist Financial
Charlotte,
North Carolina
|
+$75K |
| 5 |
Capstone Investment Advisors
New York
|
+$63K |
Top Sellers
| 1 | -$1.93M | |
| 2 | -$924K | |
| 3 | -$588K | |
| 4 |
CA
CHI Advisors
New York
|
-$329K |
| 5 |
BlackRock
New York
|
-$326K |